Why Rigel (RIGL) Could Beat Earnings Estimates Again

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Rigel Pharmaceuticals (RIGL) , which belongs to the Zacks Medical - Drugs industry, could be a great candidate to consider.This drug developer has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 197.73%.For the most recent quarter, Rigel was expect ...